Moreover, direct targeting of tumor-associated antigens (TAAs) to antigen presenting cells (APC) is more likely to occur with enriched membrane-bound GM-CSF on tumor cells and their receptors on DCs. This evidence concerns the gene CSF2 and neoplasm.